相似文献
1
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007.
2
Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):253-6. doi: 10.1016/j.jalz.2011.04.003.
3
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.
4
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.
5
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.
Alzheimers Dement. 2011 May;7(3):335-7. doi: 10.1016/j.jalz.2011.04.002.
6
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73. doi: 10.1097/NEN.0b013e31824b211b.
7
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
8
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease".
Alzheimers Dement. 2011 May;7(3):333-4. doi: 10.1016/j.jalz.2011.04.001.
9
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
10
Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.
J Neuropathol Exp Neurol. 2017 Jan 1;76(1):39-43. doi: 10.1093/jnen/nlw104.
引用本文的文献
1
Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank.
Mol Psychiatry. 2025 Aug 28. doi: 10.1038/s41380-025-03166-y.
2
Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.
Int J Mol Sci. 2025 Aug 13;26(16):7819. doi: 10.3390/ijms26167819.
3
Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review.
Mar Drugs. 2025 Jul 30;23(8):310. doi: 10.3390/md23080310.
4
Key questions for the future of amyloid research in dementia: a framework for integrating complex datasets.
Mol Psychiatry. 2025 Aug 22. doi: 10.1038/s41380-025-03156-0.
5
Hippocampal tau distribution in primary age-related tauopathy: The Vantaa 85+ Study.
Alzheimers Dement. 2025 Aug;21(8):e70613. doi: 10.1002/alz.70613.
6
Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson's disease.
Res Sq. 2025 Aug 11:rs.3.rs-6647341. doi: 10.21203/rs.3.rs-6647341/v1.
7
F-FDG PET in detection of primary age-related tauopathy (PART) - Is there a role? Insights from an imaging-pathology correlation study.
Alzheimers Dement. 2025 Aug;21(8):e70568. doi: 10.1002/alz.70568.
8
Pathologic burden goes with the flow: MRI perfusion and pathologic burden in frontotemporal lobar degeneration due to tau.
Imaging Neurosci (Camb). 2024 Mar 22;2. doi: 10.1162/imag_a_00118. eCollection 2024.
9
MIND Diet and Hippocampal Sclerosis Among Community-Based Older Adults.
JAMA Netw Open. 2025 Aug 1;8(8):e2526089. doi: 10.1001/jamanetworkopen.2025.26089.
10
Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.
Eur J Nucl Med Mol Imaging. 2025 Aug 6. doi: 10.1007/s00259-025-07457-y.
本文引用的文献
1
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.
2
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
Stroke. 2011 Sep;42(9):2672-713. doi: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21.
3
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis.
Epidemiology. 2011 Sep;22(5):646-59. doi: 10.1097/EDE.0b013e31822708b5.
4
Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression.
Am J Geriatr Psychiatry. 2011 Jul;19(7):607-17. doi: 10.1097/JGP.0b013e3181f17eed.
5
Hippocampal sclerosis in advanced age: clinical and pathological features.
Brain. 2011 May;134(Pt 5):1506-18. doi: 10.1093/brain/awr053.
6
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
Acta Neuropathol. 2011 Jul;122(1):49-60. doi: 10.1007/s00401-011-0831-1. Epub 2011 May 1.
7
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
8
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
9
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.
10
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nat Genet. 2011 May;43(5):436-41. doi: 10.1038/ng.801. Epub 2011 Apr 3.
Zotero 插件